SOS1 mutations in Noonan syndrome

Molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations

Francesca Lepri, Alessandro De Luca, Lorenzo Stella, Cesare Rossi, Giuseppina Baldassarre, Francesca Pantaleoni, Viviana Cordeddu, Bradley J. Williams, Maria L. Dentici, Viviana Caputo, Serenella Venanzi, Michela Bonaguro, Ines Kavamura, Maria F. Faienza, Alba Pilotta, Franco Stanzial, Francesca Faravelli, Orazio Gabrielli, Bruno Marino, Giovanni Neri & 10 others Margherita Cirillo Silengo, Giovanni B. Ferrero, Isabella Torrrente, Angelo Selicorni, Laura Mazzanti, Maria C. Digilio, Giuseppe Zampino, Bruno Dallapiccola, Bruce D. Gelb, Marco Tartaglia

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Noonan syndrome (NS) is among the most common nonchromosomal disorders affecting development and growth. NS is caused by aberrant RAS-MAPK signaling and is genetically heterogeneous, which explains, in part, the marked clinical variability documented for this Mendelian trait. Recently, we and others identified SOS1 as a major gene underlying NS. Here, we explored further the spectrum of SOS1 mutations and their associated phenotypic features. Mutation scanning of the entire SOS1 coding sequence allowed the identification of 33 different variants deemed to be of pathological significance, including 16 novel missense changes and in-frame indels. Various mutation clusters destabilizing or altering orientation of regions of the protein predicted to contribute structurally to the maintenance of autoinhibition were identified. Two previously unappreciated clusters predicted to enhance SOS1's recruitment to the plasma membrane, thus promoting a spatial reorientation of domains contributing to inhibition, were also recognized. Genotype-phenotype analysis confirmed our previous observations, establishing a high frequency of ectodermal anomalies and a low prevalence of cognitive impairment and reduced growth. Finally, mutation analysis performed on cohorts of individuals with nonsyndromic pulmonic stenosis, atrial septal defects, and ventricular septal defects excluded a major contribution of germline SOS1 lesions to the isolated occurrence of these cardiac anomalies.

Original languageEnglish
Pages (from-to)760-772
Number of pages13
JournalHuman Mutation
Volume32
Issue number7
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Noonan Syndrome
Genetic Association Studies
Mutation
Pulmonary Valve Stenosis
Atrial Heart Septal Defects
Ventricular Heart Septal Defects
Growth and Development
Genotype
Maintenance
Cell Membrane
Phenotype
Growth
Genes
Proteins

Keywords

  • Genotype-phenotype correlations
  • Mutation analysis
  • Noonan syndrome
  • NS
  • SOS1
  • Structural analysis

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

SOS1 mutations in Noonan syndrome : Molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations. / Lepri, Francesca; De Luca, Alessandro; Stella, Lorenzo; Rossi, Cesare; Baldassarre, Giuseppina; Pantaleoni, Francesca; Cordeddu, Viviana; Williams, Bradley J.; Dentici, Maria L.; Caputo, Viviana; Venanzi, Serenella; Bonaguro, Michela; Kavamura, Ines; Faienza, Maria F.; Pilotta, Alba; Stanzial, Franco; Faravelli, Francesca; Gabrielli, Orazio; Marino, Bruno; Neri, Giovanni; Silengo, Margherita Cirillo; Ferrero, Giovanni B.; Torrrente, Isabella; Selicorni, Angelo; Mazzanti, Laura; Digilio, Maria C.; Zampino, Giuseppe; Dallapiccola, Bruno; Gelb, Bruce D.; Tartaglia, Marco.

In: Human Mutation, Vol. 32, No. 7, 07.2011, p. 760-772.

Research output: Contribution to journalArticle

Lepri, F, De Luca, A, Stella, L, Rossi, C, Baldassarre, G, Pantaleoni, F, Cordeddu, V, Williams, BJ, Dentici, ML, Caputo, V, Venanzi, S, Bonaguro, M, Kavamura, I, Faienza, MF, Pilotta, A, Stanzial, F, Faravelli, F, Gabrielli, O, Marino, B, Neri, G, Silengo, MC, Ferrero, GB, Torrrente, I, Selicorni, A, Mazzanti, L, Digilio, MC, Zampino, G, Dallapiccola, B, Gelb, BD & Tartaglia, M 2011, 'SOS1 mutations in Noonan syndrome: Molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations', Human Mutation, vol. 32, no. 7, pp. 760-772. https://doi.org/10.1002/humu.21492
Lepri, Francesca ; De Luca, Alessandro ; Stella, Lorenzo ; Rossi, Cesare ; Baldassarre, Giuseppina ; Pantaleoni, Francesca ; Cordeddu, Viviana ; Williams, Bradley J. ; Dentici, Maria L. ; Caputo, Viviana ; Venanzi, Serenella ; Bonaguro, Michela ; Kavamura, Ines ; Faienza, Maria F. ; Pilotta, Alba ; Stanzial, Franco ; Faravelli, Francesca ; Gabrielli, Orazio ; Marino, Bruno ; Neri, Giovanni ; Silengo, Margherita Cirillo ; Ferrero, Giovanni B. ; Torrrente, Isabella ; Selicorni, Angelo ; Mazzanti, Laura ; Digilio, Maria C. ; Zampino, Giuseppe ; Dallapiccola, Bruno ; Gelb, Bruce D. ; Tartaglia, Marco. / SOS1 mutations in Noonan syndrome : Molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations. In: Human Mutation. 2011 ; Vol. 32, No. 7. pp. 760-772.
@article{08360280f3b74acc9f92e7de5bb73512,
title = "SOS1 mutations in Noonan syndrome: Molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations",
abstract = "Noonan syndrome (NS) is among the most common nonchromosomal disorders affecting development and growth. NS is caused by aberrant RAS-MAPK signaling and is genetically heterogeneous, which explains, in part, the marked clinical variability documented for this Mendelian trait. Recently, we and others identified SOS1 as a major gene underlying NS. Here, we explored further the spectrum of SOS1 mutations and their associated phenotypic features. Mutation scanning of the entire SOS1 coding sequence allowed the identification of 33 different variants deemed to be of pathological significance, including 16 novel missense changes and in-frame indels. Various mutation clusters destabilizing or altering orientation of regions of the protein predicted to contribute structurally to the maintenance of autoinhibition were identified. Two previously unappreciated clusters predicted to enhance SOS1's recruitment to the plasma membrane, thus promoting a spatial reorientation of domains contributing to inhibition, were also recognized. Genotype-phenotype analysis confirmed our previous observations, establishing a high frequency of ectodermal anomalies and a low prevalence of cognitive impairment and reduced growth. Finally, mutation analysis performed on cohorts of individuals with nonsyndromic pulmonic stenosis, atrial septal defects, and ventricular septal defects excluded a major contribution of germline SOS1 lesions to the isolated occurrence of these cardiac anomalies.",
keywords = "Genotype-phenotype correlations, Mutation analysis, Noonan syndrome, NS, SOS1, Structural analysis",
author = "Francesca Lepri and {De Luca}, Alessandro and Lorenzo Stella and Cesare Rossi and Giuseppina Baldassarre and Francesca Pantaleoni and Viviana Cordeddu and Williams, {Bradley J.} and Dentici, {Maria L.} and Viviana Caputo and Serenella Venanzi and Michela Bonaguro and Ines Kavamura and Faienza, {Maria F.} and Alba Pilotta and Franco Stanzial and Francesca Faravelli and Orazio Gabrielli and Bruno Marino and Giovanni Neri and Silengo, {Margherita Cirillo} and Ferrero, {Giovanni B.} and Isabella Torrrente and Angelo Selicorni and Laura Mazzanti and Digilio, {Maria C.} and Giuseppe Zampino and Bruno Dallapiccola and Gelb, {Bruce D.} and Marco Tartaglia",
year = "2011",
month = "7",
doi = "10.1002/humu.21492",
language = "English",
volume = "32",
pages = "760--772",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - SOS1 mutations in Noonan syndrome

T2 - Molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations

AU - Lepri, Francesca

AU - De Luca, Alessandro

AU - Stella, Lorenzo

AU - Rossi, Cesare

AU - Baldassarre, Giuseppina

AU - Pantaleoni, Francesca

AU - Cordeddu, Viviana

AU - Williams, Bradley J.

AU - Dentici, Maria L.

AU - Caputo, Viviana

AU - Venanzi, Serenella

AU - Bonaguro, Michela

AU - Kavamura, Ines

AU - Faienza, Maria F.

AU - Pilotta, Alba

AU - Stanzial, Franco

AU - Faravelli, Francesca

AU - Gabrielli, Orazio

AU - Marino, Bruno

AU - Neri, Giovanni

AU - Silengo, Margherita Cirillo

AU - Ferrero, Giovanni B.

AU - Torrrente, Isabella

AU - Selicorni, Angelo

AU - Mazzanti, Laura

AU - Digilio, Maria C.

AU - Zampino, Giuseppe

AU - Dallapiccola, Bruno

AU - Gelb, Bruce D.

AU - Tartaglia, Marco

PY - 2011/7

Y1 - 2011/7

N2 - Noonan syndrome (NS) is among the most common nonchromosomal disorders affecting development and growth. NS is caused by aberrant RAS-MAPK signaling and is genetically heterogeneous, which explains, in part, the marked clinical variability documented for this Mendelian trait. Recently, we and others identified SOS1 as a major gene underlying NS. Here, we explored further the spectrum of SOS1 mutations and their associated phenotypic features. Mutation scanning of the entire SOS1 coding sequence allowed the identification of 33 different variants deemed to be of pathological significance, including 16 novel missense changes and in-frame indels. Various mutation clusters destabilizing or altering orientation of regions of the protein predicted to contribute structurally to the maintenance of autoinhibition were identified. Two previously unappreciated clusters predicted to enhance SOS1's recruitment to the plasma membrane, thus promoting a spatial reorientation of domains contributing to inhibition, were also recognized. Genotype-phenotype analysis confirmed our previous observations, establishing a high frequency of ectodermal anomalies and a low prevalence of cognitive impairment and reduced growth. Finally, mutation analysis performed on cohorts of individuals with nonsyndromic pulmonic stenosis, atrial septal defects, and ventricular septal defects excluded a major contribution of germline SOS1 lesions to the isolated occurrence of these cardiac anomalies.

AB - Noonan syndrome (NS) is among the most common nonchromosomal disorders affecting development and growth. NS is caused by aberrant RAS-MAPK signaling and is genetically heterogeneous, which explains, in part, the marked clinical variability documented for this Mendelian trait. Recently, we and others identified SOS1 as a major gene underlying NS. Here, we explored further the spectrum of SOS1 mutations and their associated phenotypic features. Mutation scanning of the entire SOS1 coding sequence allowed the identification of 33 different variants deemed to be of pathological significance, including 16 novel missense changes and in-frame indels. Various mutation clusters destabilizing or altering orientation of regions of the protein predicted to contribute structurally to the maintenance of autoinhibition were identified. Two previously unappreciated clusters predicted to enhance SOS1's recruitment to the plasma membrane, thus promoting a spatial reorientation of domains contributing to inhibition, were also recognized. Genotype-phenotype analysis confirmed our previous observations, establishing a high frequency of ectodermal anomalies and a low prevalence of cognitive impairment and reduced growth. Finally, mutation analysis performed on cohorts of individuals with nonsyndromic pulmonic stenosis, atrial septal defects, and ventricular septal defects excluded a major contribution of germline SOS1 lesions to the isolated occurrence of these cardiac anomalies.

KW - Genotype-phenotype correlations

KW - Mutation analysis

KW - Noonan syndrome

KW - NS

KW - SOS1

KW - Structural analysis

UR - http://www.scopus.com/inward/record.url?scp=79959745810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959745810&partnerID=8YFLogxK

U2 - 10.1002/humu.21492

DO - 10.1002/humu.21492

M3 - Article

VL - 32

SP - 760

EP - 772

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 7

ER -